Loading financial data...

Taysha Gene Therapies, Inc. (TSHA) SEC Filings | Global Financial Data

Taysha Gene Therapies, Inc.

TSHASEC EDGAR

Biological Products, (No Diagnostic Substances)(DE)CIK: 1806310

Filed: Feb 6, 2026 | Report: Feb 4, 2026

Filed: Jan 27, 2026 | Report: Jan 23, 2026

View on SEC

Filed: Jan 27, 2026 | Report: Jan 23, 2026

View on SEC

Filed: Jan 27, 2026 | Report: Jan 23, 2026

Filed: Jan 14, 2026 | Report: Jan 12, 2026

View on SEC

Filed: Jan 14, 2026 | Report: Jan 12, 2026

View on SEC

Filed: Jan 14, 2026 | Report: Jan 12, 2026

Filed: Dec 1, 2025 | Report: Nov 28, 2025

Filed: Nov 4, 2025 | Report: Nov 4, 2025

View on SEC

10-Q

Filed: Nov 4, 2025 | Report: Sep 30, 2025

View on SEC

8-K

Filed: Oct 16, 2025 | Report: Oct 16, 2025

View on SEC

8-K

Filed: Oct 9, 2025 | Report: Oct 9, 2025

View on SEC

8-K

Filed: Oct 2, 2025 | Report: Oct 2, 2025

Filed: Sep 12, 2025 | Report: Sep 10, 2025

Filed: Aug 22, 2025 | Report: Aug 21, 2025

View on SEC

Filed: Aug 22, 2025 | Report: Aug 21, 2025

Filed: Aug 12, 2025 | Report: Jun 30, 2025

View on SEC

8-K

Filed: Aug 12, 2025 | Report: Aug 12, 2025

View on SEC

Build with this data

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)

Get API Key (Free)